An ultraefficient affinity-based high-throughout screening process: Application to bacterial cell wall biosynthesis enzyme MurF

被引:58
作者
Comess, Kenneth M.
Schurdak, Mark E.
Voorbach, Martin J.
Coen, Michael
Trumbull, Jonathan D.
Yang, Houjun
Gao, Lan
Tang, Hua
Cheng, Xueheng
Lerner, Claude G.
McCall, Owen
Burns, David J.
Beutel, Bruce A.
机构
[1] Global Pharmaceut R&D, Dept Target & Lead Discovery, Abbott Labs, Abbott Pk, IL 60064 USA
[2] Global Pharmaceut R&D, Dept Metab Dis Res, Abbott Labs, Abbott Pk, IL 60064 USA
[3] Global Pharmaceut R&D, Dept Adv Technol, Abbott Labs, Abbott Pk, IL 60064 USA
[4] Global Pharmaceut R&D, Dept Canc Res, Abbott Labs, Abbott Pk, IL 60064 USA
关键词
MurF; Streptococcus pneumoniae; affinity-based HTS; mass spectrometry; promiscuous binder analysis;
D O I
10.1177/1087057106289971
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The authors describe the discovery of a new class of inhibitors to an essential Streptococcus pneumoniae cell wall biosynthesis enzyme, MurF, by a novel affinity screening method. The strategy involved screening very large mixtures of diverse small organic molecules against the protein target on the basis of equilibrium binding, followed by iterative ultrafiltration steps and ligand identification by mass spectrometry. Hits from any affinity-based screening method often can be relatively nonselective ligands, sometimes referred to as "nuisance" or "promiscuous" compounds. Ligands selective in their binding affinity for the MurF target were readily identified through electronic subtraction of an empirically determined subset of promiscuous compounds in the library without subsequent selectivity panels. The complete strategy for discovery and identification of novel specific ligands can be applied to all soluble protein targets and a wide variety of ligand libraries.
引用
收藏
页码:743 / 754
页数:12
相关论文
共 41 条
[1]   Hit and lead generation:: Beyond high-throughput screening [J].
Bleicher, KH ;
Böhm, HJ ;
Müller, K ;
Alanine, AI .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378
[2]   Kinase drug discovery by affinity selection/mass spectrometry (ASMS): Application to DNA damage checkpoint kinase Chk1 [J].
Comess, Kenneth M. ;
Trumbull, Jonathan D. ;
Park, Chang ;
Chen, Zehan ;
Judge, Russell A. ;
Voorbach, Martin J. ;
Coen, Michael ;
Gao, Lan ;
Tang, Hua ;
Kovar, Peter ;
Cheng, Xueheng ;
Schurdak, Mark E. ;
Zhang, Haiying ;
Sowin, Tom ;
Burns, David J. .
JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (07) :755-764
[3]   High-throughput NMR-based screening with competition binding experiments [J].
Dalvit, C ;
Flocco, M ;
Knapp, S ;
Mostardini, M ;
Perego, R ;
Stockman, BJ ;
Veronesi, M ;
Varasi, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (26) :7702-7709
[4]   Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa [J].
Dickopf, S ;
Frank, M ;
Junker, HD ;
Maier, S ;
Metz, G ;
Ottleben, H ;
Rau, H ;
Schellhaas, N ;
Schmidt, K ;
Sekul, R ;
Vanier, C ;
Vetter, D ;
Czech, J ;
Lorenz, M ;
Matter, H ;
Schudok, M ;
Schreuder, H ;
Will, DW ;
Nestler, HP .
ANALYTICAL BIOCHEMISTRY, 2004, 335 (01) :50-57
[5]   Structure and function of the Mur enzymes: development of novel inhibitors [J].
El Zoeiby, A ;
Sanschagrin, F ;
Levesque, RC .
MOLECULAR MICROBIOLOGY, 2003, 47 (01) :1-12
[6]   Lead compounds discovered from libraries: Part 2 [J].
Golebiowski, A ;
Klopfenstein, SR ;
Portlock, DE .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (03) :308-325
[7]   Small molecule lead generation processes for drug discovery [J].
Goodnow, R .
DRUGS OF THE FUTURE, 2002, 27 (12) :1165-1180
[8]   Current practices in generation of small molecule new leads [J].
Goodnow, RA .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2001, 84 :13-21
[9]   Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry [J].
Griffey, RH ;
Hofstadler, SA ;
Sannes-Lowery, KA ;
Ecker, DJ ;
Crooke, ST .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10129-10133
[10]   Structure-activity relationships of novel potent MurF inhibitors [J].
Gu, YG ;
Florjancic, AS ;
Clark, RF ;
Zhang, TY ;
Cooper, CS ;
Anderson, DD ;
Lerner, CG ;
McCall, JO ;
Cai, YN ;
Black-Schaefer, CL ;
Stamper, GF ;
Hajduk, PJ ;
Beutel, BA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) :267-270